Navigation Links
Highly Effective Method for Screening Drug-resistant Forms of HIV Developed

University of Pennsylvania researchers have developed a new method for screening drug-resistance forms of HIV that saves both time and money.

Dr. Frederic D. Bushman, Professor of Microbiology at the University of Pennsylvania School of Medicine, combined two genetic tests, which enabled him to rapidly obtained gene sequences from multiple drug-resistant HIV samples at once.

"There is considerable interest in identifying minor drug resistant variants prior to initiating new therapy, in order to allow treatment with the most effective drugs," explains Dr. Bushman, whose study appears online in Nucleic Acids Research.

"Treatment of HIV infection often fails because viruses mutate to resist drugs. Under the pressure of drug treatment, small populations of resistant viruses can quickly grow to become the majority, resulting in treatment failure due to drug resistance," he adds.

Around 40 million people across the world are currently living with HIV/AIDS, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The commonly prescribed cocktails of antiretroviral drugs help slow the debilitating effects of the virus by disrupting it at various stages in its replication, but still quickly mutating forms of HIV can complicate treatment outcomes.

The researchers reckon that nearly 50 per cent of individuals being treated for HIV in the US carry drug-resistant forms of HIV, which was either caused by mutations in the virus in response to drug treatment or by infection with a resistant form of the virus. They feel that the increased availability of antiretroviral drugs to meet the HIV/AIDS needs of developing countries in recent years may lead to a global rise in drug-resistant strains of HIV.

"To overcome drug resistance, patients must be treated with drugs to which the HIV virus is still susceptible," says Bushman.

Due high costs of Antiretroviral resistance screenings, which help tailor the most effective anti-HIV treatment before a patient begins or changes drug therapy, developing countries rarely use them. Where resistance testing is available, most screening techniques are not sensitive enough to analyse small populations of drug-resistant strains of HIV.

With a view to increase the sensitivity of HIV screening techniques and decrease the time and cost of the tests, Dr. Bushman examined seven samples of mutated strains of HIV, including three HIV samples from patients who had experienced antiretroviral multi-drug resistance.

The DNA bar coding, wherein different DNA molecules are indexed using DNA sequence tags, helped the researcher map multiple sequences of HIV mutants simultaneously. He identified drug-resistant mutations by using a new DNA sequencing technique called pyrosequencing, which enables determination of millions of bases of a DNA sequence in a single one-day experiment.

When the two methods were combined, the researchers were able to quantify and characterize hundreds of thousands of HIV variants for drug resistance in a single test. The new screening technique also uncovered four rare, minor drug-resistant mutations in the patient samples of HIV that had gone undetected by standard screening measures.

Dr. Bushman believes that these small drug-resistant populations of HIV may explain why some patients do not respond to antiretroviral treatment, as the minor alleles can rapidly grow out, generating new populations of drug-resistant viruses.

He is now planning to apply the new method to optimise drug-resistance testing in the US, and several developing countries.

"Thanks to DNA bar coding and pyrosequencing, clinicians should be able to optimize treatment for their patients with much more relevant information in front of them," says Bushman.


'"/>




Related medicine news :

1. Highly Educated More Prone To Parkinsons Disease
2. Alzheimers Disease Progresses Rapidly In Highly Educated
3. Mapping Of Brain Highly Beneficial For Safer Brain Tumor Surgery
4. Highly Pure Form Of heroin Proving To be lethal Killer
5. Highly Potent TB Strain Plays Favorites Targeting Specific Ethnic Groups
6. Highly-Concentrated Botulinum Preparation Can Result in Severe Illness
7. Therapy Modulates Highly Sensitized Immune System to Let Mother Give Kidney to Daughter
8. Act Now To Cleanse Highly Polluted River Hindon, Says Study
9. Four Gay Men Carrying Highly Multiple-drug Resistant Strain of HIV Reported
10. New Treatment For Psoriasis Is Highly Effective
11. Nonsurgical Therapy Highly Effective for Pain and Infertility in Men
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
Breaking Medicine Technology: